C 19 H 18 Br 2 O4, monoclinic, P21/n (no. 14), a = 14.323 (3) 
The crystal structure is shown in the gure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
The title compound was synthesized according to a reported procedure [1] . A mixture of 3,5-cyclohexanedione (20 mmol) and 3,5-dibromo-benzaldehyde (10 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then cooled to room temperature. After ltering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under vacuum.
Experimental details
Hydrogen atoms were placed in calculated positions and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C) and 1.5Ueq(O).
Discussion
Bis-enone derivatives are widely available in nature. Some derivatives exhibit biological activities, such as anticoagulant, insecticidal, antihelminthic, hypnotic, and antifungal activities, phytoalexin production, and HIV protease inhibition [2] [3] [4] . Moreover, these compounds are gaining increasing interest because of their versatile 
activities through chemical modi cations (di erent substituents at the phenyl moiety) [5] . Recognizing the considerable importance of the compounds, research focused on the synthesis of bis-enone derivatives.
In the crystal structure of the title compound, the central six-membered ring containing one oxygen atom is almost perpendicular to the dibromo-phenyl moiety. The mean planes of the two annulated six-membered rings are almost parallel to the aforementioned oxan-2-enyl moiety.
